Travel & financial grants

Bristol-Myers Squibb

This page describes Bristol Myers Squibb's patient assistance programs focused on helping patients afford their prescription medicines. This includes assistance with understanding insurance coverage, co-pay assistance for commercially insured patients, and free medication for eligible uninsured patients experiencing financial hardship. No information regarding travel assistance grants is provided on this page.

Bristol-Myers Squibb

This page describes the Bristol Myers Squibb Patient Assistance Program, which provides financial assistance for prescription medicines to eligible U.S. residents. It offers help understanding insurance coverage, co-pay assistance for commercially insured patients, and free medication for uninsured patients experiencing financial hardship. The content does not mention any coverage for travel expenses such as flights, hotels, or gas.

Bristol-Myers Squibb

This page describes Bristol Myers Squibb's patient assistance programs, which primarily offer financial support for the cost of their prescription medicines. Programs include co-pay assistance for commercially insured patients and free medication for eligible, uninsured patients experiencing financial hardship. No information regarding patient travel assistance grants is provided on this page.

Bristol-Myers Squibb

This program provides financial assistance for Bristol Myers Squibb prescription medicines, offering co-pay support for commercially-insured patients and free medication for eligible, uninsured patients experiencing financial hardship. The page content does not indicate that this grant provides any form of travel assistance.

Ipsen

This page provides information about the drug Bylvay and notes that it is supported by a program designed to assist with access to treatment and patient support. However, the page does not contain any details about a travel assistance grant or coverage for travel-related expenses.

CancerCare

CancerCare

CancerCare

CancerCare

CancerCare

The CancerCare: Uterine/Endometrial Cancer program offers financial assistance for individuals undergoing treatment for uterine or endometrial cancer who reside in the US and Puerto Rico. It helps cover copayments and coinsurance for chemotherapy or targeted treatment medications, and other treatment-related expenses like transportation, home care, and childcare, with an initial grant of $6,000 and an annual maximum of $10,000. Eligibility is needs-based, primarily for those insured through federal programs (Medicare/Medicaid), and privately insured patients must first apply to manufacturer programs.

CancerCare

The CancerCare: Cancer Related Pain Management program offers financial assistance for copayments and coinsurance for chemotherapy or targeted treatment medications, as well as support for treatment-related expenses like transportation, home care, and childcare. Grants can go up to $20,000 annually. It is available for US and Puerto Rico residents with a cancer diagnosis who demonstrate financial need and have eligible cancer drugs covered by their primary insurance.

CancerCare

The CancerCare Metastatic Breast Cancer Financial Assistance Program provides grants up to $10,000 annually for patients with metastatic breast cancer who are insured through federal programs (Medicare/Medicaid) and demonstrate financial need. It covers copayments and coinsurance for chemotherapy or targeted treatment medications, in addition to treatment-related expenses like transportation, home care, and childcare costs. Eligibility requires an interview with a CancerCare social worker to initiate the application process.

CancerCare

The CancerCare Metastatic Colorectal Cancer program offers financial assistance for co-payment and coinsurance costs for approved cancer drugs, and also assists with treatment-related expenses such as transportation. Eligible US and Puerto Rico residents with metastatic colorectal cancer who meet insurance and income criteria can receive up to $10,000 annually. Patients with private insurance must apply to manufacturer programs first and undergo an interview with a CancerCare social worker.

CancerCare

This CancerCare program provides financial assistance for patients undergoing treatment for metastatic prostate cancer, covering co-payment and coinsurance for cancer drugs, as well as related expenses like transportation, home care, and childcare. It is a needs-based program with an initial grant amount of $7,500 and an annual maximum benefit of $10,000. Eligible patients require enrollment and must meet specific insurance requirements, including applying to manufacturer programs first if privately insured.

CancerCare

This CancerCare grant offers assistance to patients with metastatic non-melanoma skin cancer who are undergoing treatment with specific drugs (e.g., Carac, Erivedge, Odomzo) and are insured through federal health programs. It covers co-payment and coinsurance for chemotherapy/targeted treatment medications, as well as treatment-related expenses like transportation, home care, and childcare costs. Eligibility is needs-based, requiring an interview and submission of income documentation.

CancerCare

CancerCare

The CancerCare Myeloproliferative Neoplasms Financial Assistance Program offers needs-based financial support for patients with conditions like Thrombocythemia, Polycythemia Vera, and Myelofibrosis. It covers co-payment and coinsurance for chemotherapy or targeted treatment medications, along with treatment-related expenses such as transportation, home care, and childcare costs, with annual grants up to $10,000. Patients must be enrolled in Medicare/Medicaid or apply to manufacturer programs first if privately insured.

CancerCare

The CancerCare: Desmoid Tumor program offers financial assistance for co-payments and coinsurance related to chemotherapy and targeted treatments, as well as support for transportation, home care, and childcare costs. Eligibility requires residents of the US and Puerto Rico with a Desmoid Tumor diagnosis and a demonstrated financial need, having commercial insurance, Medicare, or Medicaid.

CancerCare

The CancerCare: Multiple Myeloma grant offers financial assistance to insured patients undergoing active treatment for multiple myeloma, covering co-payment and coinsurance for chemotherapy and related medications. It also provides support for treatment-related expenses such as transportation, home care, and childcare costs. This needs-based program has an initial grant amount of $7,000 and an annual maximum benefit of $10,000.

Sanofi

The CareConnectPSS Copay Assistance Program assists eligible U.S. patients prescribed Fabrazyme by covering their out-of-pocket drug costs and certain infusion-related expenses, including copays, coinsurance, and deductibles. Patients whose costs are covered by state or federal healthcare programs are not eligible. The program explicitly does not cover transportation or other related services beyond drug and infusion expenses.

PAN Foundation

This PAN Foundation grant provides assistance for medication copays to patients with Chronic Kidney Disease (CKD). While primarily for medication, the foundation's grants generally include coverage for transportation purchases. Eligibility requires verification of income or insurance premium.

CreakyJoints

This resource by CreakyJoints compiles various co-pay cards, pharmaceutical assistance programs, and patient assistance foundations to help arthritis patients afford their medications. These programs offer discounts, rebates, or free medication for prescription costs. Eligibility criteria, including income requirements, vary widely for each individual program listed, but generally target patients with commercial or private insurance not covered by federal or state health care programs.

The Assistance Fund

The Cold Agglutinin Disease Financial Assistance Program provides grants to patients diagnosed with the disease who are prescribed an FDA-approved treatment and meet financial eligibility criteria. It covers out-of-pocket costs such as prescription drugs, health insurance premiums, and therapy administration. Additionally, it offers financial assistance for travel expenses, including ground transportation, air travel, meals, and hotel stays, for appointments at treatment centers or with prescribing physicians.

Exelixis

The Exelixis Access Services (EASE) program provides financial assistance for the medication COMETRIQ, not travel-related expenses. It offers a co-pay program for commercially insured patients and a patient assistance program for uninsured or underinsured patients who meet eligibility criteria and cannot afford their medicine.

Novartis

The COSENTYX Connect Personal Support Program, offered by the manufacturer of COSENTYX, provides a range of helpful resources and tools for patients. No specific income requirements or coverage types like travel assistance are explicitly detailed.

CreakyJoints

This page from CreakyJoints compiles information on various co-pay cards and financial assistance programs primarily offered by pharmaceutical companies to help arthritis patients cover the costs of their medications. It does not offer or list any grants specifically for patient travel assistance. Eligibility and coverage details vary for each individual program presented.

CreakyJoints

This page provides a directory of co-pay cards and financial assistance programs for arthritis patients, designed to help cover the costs of expensive medications. These programs are offered by various manufacturers and foundations, aiming to reduce out-of-pocket expenses for eligible patients. The page does not contain information about travel assistance.

CreakyJoints

This page from CreakyJoints serves as a directory of co-pay cards and financial assistance programs, primarily aimed at helping arthritis patients reduce the out-of-pocket costs for their medications. It compiles information from various pharmaceutical manufacturers and independent foundations. The programs detailed do not offer travel assistance.

CreakyJoints

The CreakyJoints Co-pay Cards and Financial Assistance resource is a directory compiling various programs designed to help arthritis patients afford their medications. It lists co-pay cards, pharmaceutical assistance programs, and patient assistance foundations from various manufacturers and organizations. These programs offer savings on prescription co-payments, reduced prices, or free medications, with eligibility criteria varying by program.

The Assistance Fund

The Cystinosis Assistance Fund offers financial assistance to individuals in the US and Puerto Rico diagnosed with cystinosis. It covers copays, coinsurance, deductibles, health insurance premiums, and other eligible out-of-pocket medical expenses for FDA-approved and potentially off-label treatments like Procysbi, Cystaran, Cystagon, and Cystadrops. Eligibility is needs-based and requires commercial, Medicare, or Medicaid insurance.

Johnson & Johnson

The DARZALEX withMe program assists patients prescribed DARZALEX or DARZALEX FASPRO by offering support with medication costs. This includes a savings program for commercially insured patients and a patient assistance program providing free medication for up to one year for eligible uninsured patients. Care navigators also connect patients with community resources, including transportation-related services.

Bristol Myers-Squibb

This page lists the Destination Access Sprycel (Dasatinib) grant as a program offered by Bristol Myers-Squibb. However, the page does not provide details on what the grant covers, its specific eligibility requirements, or how to apply.